Nancy Pezeshki, PHARM. D. Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 16461 Ventura Blvd, Encino, CA 91436 Phone: 818-986-2117 |
Dr. Babak Fatirian, PHARM-D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17479 Ventura Blvd, Encino, CA 91316 Phone: 818-514-4020 Fax: 818-514-4025 |
Donald Blumkin, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5353 Balboa Blvd, Encino, CA 91316 Phone: 818-788-2411 Fax: 818-981-4947 |
Dr. Ravash Nejathaim, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5041 Enfield Ave, Encino, CA 91316 Phone: 818-312-8173 |
Ms. Suzette Alcantara Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16100 Ventura Blvd, Encino, CA 91436 Phone: 818-788-6951 |
Neggy Ghalchi, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16025 Ventura Blvd Ste 100, Encino, CA 91436 Phone: 818-377-6900 Fax: 818-377-9195 |
Masha Safransky, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16325 Ventura Blvd, Encino, CA 91436 Phone: 818-728-4515 |
Dr. Mitra Moaddelly Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17717 Martha St, Encino, CA 91316 Phone: 818-881-4757 |
Jasmine Hashemieh-estes Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17200 Ventura Blvd Ste 116, Encino, CA 91316 Phone: 818-968-2422 Fax: 818-907-8238 |
Polina Neminov, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16325 Ventura Blvd, Encino, CA 91436 Phone: 818-728-4515 |
Dr. Abdolreza Kossarian, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17864 Ventura Blvd, Encino, CA 91316 Phone: 818-345-5456 Fax: 818-345-9846 |
News Archive
Primary school children should not be routinely screened for obesity without any sound evidence of benefit, suggests research published ahead of print in the Archives of Disease in Childhood.
Genta Incorporated has announced the release of final results from the Company's Phase 1 clinical trial of G4544, a proprietary small molecule that is intended as a treatment for diseases associated with accelerated bone loss. Results showed that the drug was very well-tolerated, and that blood levels were achieved in a range that is known to be clinically bioactive. The data were featured in a poster session at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago on Saturday, May 31, 2008.
Professor Michael Davies will tell the annual meeting of the European Society of Human Reproduction and Embryology today that the "vanishing twin" phenomenon, in which only one child is born from a pregnancy that originally starts as a multiple pregnancy, is linked to a nearly two-fold increased risk in any congenital malformation and to a nearly three-fold risk of multiple malformations.
"During the past 24 hours, cholera has claimed the lives of nearly 200 women and children in famine-stricken Somalia," a Press TV correspondent in Mogadishu reported on Sunday. "More than 800 children suffering from the disease in refugee camps were reportedly transported to medical centers in south Mogadishu," the news service writes, adding, "As the number of sick is on the rise, doctors are facing a shortage of medicine."
Seattle Genetics, Inc. today announced that data from its brentuximab vedotin and dacetuzumab programs will be presented at the 11th International Conference on Malignant Lymphoma being held June 15-18, 2011 in Lugano, Switzerland.
› Verified 8 days ago